当前位置: 首页 >> 检索结果
共有 4689 条符合本次的查询结果, 用时 3.0664902 秒

321. Is the Molecular Classification of ERBB2 in Stage III Colon Cancer Clinically Ready?

作者: Jianwei Liu.
来源: Gastroenterology. 2025年169卷4期754-755页

322. The potential value of serum pepsinogen and gastrin-17 for the diagnosis of chronic atrophic gastritis at different stages of severity: a clinical diagnostic study.

作者: Tianyi Zhang.;Xuyun Zhou.;Xiangxiang Meng.;Jianxin Li.;Sujun Hou.;Junmei Wang.;Mengmeng Yin.;Long Cao.;Baitian Wang.
来源: BMC Gastroenterol. 2025年25卷1期428页
Pepsinogen (PG) and gastrin-17 (G-17) are crucial in the gastric digestive processes. This study aimed to assess the diagnostic value of the serum PG and G-17 in identifying chronic atrophic gastritis (CAG) at different stages of severity under varying Helicobacter pylori (H. pylori) infection statuses.

323. Feasibility, effectiveness, and safety of simultaneous side-by-side deployment of uncovered self-expandable metal stents for malignant hilar biliary obstruction: a retrospective single-center study.

作者: Chengcheng Christine Zhang.;Marcus Kantowski.;Cyrill Wehling.;Patrick Michl.;Ronald Koschny.;Peter Sauer.
来源: BMC Gastroenterol. 2025年25卷1期431页
Malignant hilar biliary obstruction is associated with a poor prognosis, making biliary drainage important for improving the quality of life. Endoscopic simultaneous side-by-side deployment of uncovered self-expandable metal stents is a novel approach. However, reliable clinical data on this method are limited. This retrospective, single-center study aimed to evaluate the feasibility, effectiveness, and safety of simultaneous side-by-side deployment of self-expandable metal stents for malignant hilar biliary obstruction.

324. Quantitative literature analysis on efficacy and safety of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma.

作者: Wei Fan Sui.;Yu Xin Duan.;Ze Feng Cai.;Jian Yun Li.;Jian Hua Fu.
来源: BMC Gastroenterol. 2025年25卷1期430页
To analyze the efficacy and safety of balloon-occluded transarterial chemoembolization (B-TACE) of hepatocellular carcinoma (HCC).

325. A risk prediction model for nausea and vomiting after TACE: a cross-sectional study.

作者: Yali Dai.;Mengting Zeng.;Hong He.;Miao Cai.
来源: BMC Gastroenterol. 2025年25卷1期427页
It was found that 33.8-52.5% of patients experienced nausea and vomiting after Transcatheter Arterial Chemoembolization (TACE) for liver cancer, based on prior literature. But there are no models that predict this risk. In this study, we investigated the factors associated with nausea and vomiting after TACE and developed a predictive model to predict these adverse events.

326. Predictive accuracy of fecal calprotectin in assessing clinical activity and disease severity in patients with Ulcerative Colitis and Crohn's disease.

作者: Ankit V Jain.;Sandeep Gopal.;Anurag J Shetty.;Suresh Shenoy.;B V Tantry.;B Unnikrishnan.;Ramesh Holla.;Rishit Anand.
来源: BMC Gastroenterol. 2025年25卷1期429页
Inflammatory bowel disease (IBD) is an idiopathic disorder characterized by repeated relapses and remissions. Endoscopy, the gold standard for diagnosis and monitoring of these patients is time consuming, expensive, and invasive. Hence, faecal calprotectin (FCP) has been suggested as marker to determine the degree of intestinal inflammation and predict relapse in IBD.

327. An Unusual Cause of Secondary Sclerosing Cholangitis: A Case Report.

作者: Qianyi Wang.;Jidong Jia.;Xinyan Zhao.
来源: Gastroenterology. 2025年

328. An Often-Forgotten Complication of Upadacitinib.

作者: Phillip Te.;Richard Standish.;Neel Heerasing.
来源: Gastroenterology. 2025年

329. Skipping Surgery in Rectal and Other Solid Cancers With Mismatch Repair Deficiency Using Immunotherapy.

作者: Maria D Giraldez.
来源: Gastroenterology. 2025年

330. A Case of Chronic Gastrointestinal Symptoms: Peeling Back the Mucosal Layers.

作者: Jeffrey Liu.;Katherine O Jones.;Muhammad Baraa Hammami.
来源: Gastroenterology. 2025年

331. Comparative serum imidazole propionate profiling in colorectal adenoma and cancer by UPLC-MS/MS.

作者: Jie Lv.;Qianqian Chen.;Lu Yang.;Jing Guan.;Sheng Wang.;Gen Gui.;Zhaoyun Yang.;Xu Wang.;Bin Sun.
来源: BMC Gastroenterol. 2025年25卷1期426页
The incidence of colorectal cancer (CRC) is increasing with colorectal adenomas recognized as key precancerous lesions. Emerging evidence suggests that Imidazole propionate (ImP), a metabolite of gut microbiota, is elevated in patients, indicating a potential role in tumorigenesis of CRC.

332. Global, regional, and national burden of inflammatory bowel disease in persons aged 60-89 years from 1992 to 2021.

作者: Zhou Zhang.;Na Du.;Chun-Mei Xu.;Wei Chen.; Ting-Ting-Chen.;Yu Xiao.
来源: BMC Gastroenterol. 2025年25卷1期425页
The global burden of inflammatory bowel disease (IBD) is increasing, but detailed data on older adults remain scarce.

333. Trends in incidence and mortality of early-onset gastrointestinal cancers: a comprehensive study.

作者: Chengwei Xia.;Yini Liu.;Xin Qing.
来源: BMC Gastroenterol. 2025年25卷1期424页
Early-Onset Gastrointestinal Cancers concerns tumors in people under 50. Accumulating evidence suggests a significant increase in the burden of colorectal cancer in young adults. We investigated the global burden and spatiotemporal trends of the 6 major gastrointestinal (GI) cancers, including colon and rectum cancer (CRC), esophageal cancer (EC), gallbladder and biliary tract cancer (GBTC), liver cancer (LC), pancreatic cancer (PC), and stomach cancer (SC). in young adults, based on cancer-specific incidence and mortality.

334. Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation.

作者: Hongkun Tan.;Yuyan Xu.;Cheng Zhang.;Kaihang Zhong.;Yaohong Wen.;Chunming Wang.;Zhoubin Feng.;Jianan Feng.;Shunjun Fu.;Guolin He.;Lei Cai.;Mingxin Pan.
来源: BMC Gastroenterol. 2025年25卷1期422页
Hepatocellular carcinoma (HCC) is associated with a high rate of postoperative recurrence. Postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) is effective in preventing recurrence. However, the effect of different courses of PA-TACE on tumor prognosis remains unclear. As such, this study aimed to develop and validate a nomogram that incorporates different courses of PA-TACE to predict early tumor recurrence.

335. Status of short videos as health information sources for chronic pancreatitis in China: a cross-sectional study.

作者: Xiaojing Yin.;Yongkang Lai.;Weiquan Zhu.;Ningsheng Xie.
来源: BMC Gastroenterol. 2025年25卷1期423页
Chronic pancreatitis is a chronic inflammatory disease of the pancreatic tissue caused by genetic or environmental factors; it has a complex etiology and is difficult to diagnose and treat clinically, severely affecting the physical and mental health of patients. Currently, the treatment of chronic pancreatitis often relies on lifelong self-health management by patients. However, the quality of videos related to chronic pancreatitis on short video platforms remains to be determined, and these videos may contain erroneous information that patients cannot recognize. This study aims to assess the quality of information in short videos related to chronic pancreatitis on the Chinese platforms TikTok and Bilibili.

336. Presentation of the AGA William Beaumont Prize in Gastroenterology to Evan S. Dellon, MD, MPH.

作者: Robert S Sandler.;Nicholas J Shaheen.
来源: Gastroenterology. 2025年169卷2期356-358页

337. A Rare Cause of Abdominal Distension in Infancy.

作者: Yu-Syuan Chen.;Jui-Hung Weng.;Shan-Ming Chen.
来源: Gastroenterology. 2025年

338. Shunting the Diagnosis of a Rapid Decline in Cognition.

作者: Maria Rosina Troppmair.;Benedikt Schaefer.;Martin Freund.
来源: Gastroenterology. 2025年

339. Expanding Nutrition Training in Gastroenterology: A Call to Action.

作者: Jason C Lin.;John C Lin.;Joy Zhao.;Elizabeth G Holt.;Edwin K Mcdonald.;Stephanie M Moleski.
来源: Gastroenterology. 2025年169卷4期753-754页

340. Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients.

作者: Huiling Zhu.;Mengyao Zheng.;Wenbin Li.;Yaqin Huang.;Lili Zhang.;Wenting Yang.;Jinhui Yang.
来源: BMC Gastroenterol. 2025年25卷1期421页
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear.
共有 4689 条符合本次的查询结果, 用时 3.0664902 秒